• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫检查点抑制剂治疗后挽救性扩大手术治疗晚期非小细胞肺癌。

Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer.

机构信息

Department of General Thoracic Surgery, Juntendo University School of Medicine, 1-3, Hongo 3-chome, Bunkyo-ku, Tokyo, 113-8431, Japan.

出版信息

Surg Today. 2024 Aug;54(8):917-926. doi: 10.1007/s00595-024-02812-2. Epub 2024 Mar 22.

DOI:10.1007/s00595-024-02812-2
PMID:38517532
Abstract

PURPOSE

We evaluated the surgical outcomes of salvage extended surgery after definitive medical treatment with an immune-checkpoint inhibitor (ICI) for locally advanced or unresectable non-small-cell lung cancer (NSCLC).

METHODS

The subjects of this single-center retrospective analysis were 14 patients who underwent salvage surgery after ICI treatment between May, 2017 and April, 2023 at our institute. We reviewed the comprehensive surgical outcomes, including operative procedures, intraoperative findings, and postoperative morbidities. Overall survival (OS) was calculated using a Kaplan-Meier estimation.

RESULTS

The initial clinical stage before medical treatment (c-stage) was stage III in eight patients, stage IV in five patients, and one patient had postoperative lung cancer recurrence. The indications for surgery were as follows: local control for relapse or residual tumor in ten patients and discontinuation of systemic therapy because of treatment-related complications in four patients. The surgical modes were segmentectomy (n = 1), lobectomy (n = 4), bilobectomy (n = 3), pneumonectomy (n = 6), and bronchoplasty (n = 7). Grade 3 or higher postoperative morbidities were observed in six patients, including only one case of 90-day mortality.

CONCLUSIONS

Our series demonstrated that the surgical outcome of salvage extended surgery after ICI therapy may be positive with careful selection of the procedure and indication.

摘要

目的

我们评估了免疫检查点抑制剂(ICI)治疗局部晚期或不可切除的非小细胞肺癌(NSCLC)后进行确定性治疗的挽救性扩大手术的手术结果。

方法

本单中心回顾性分析的对象是 2017 年 5 月至 2023 年 4 月在我院接受 ICI 治疗后进行挽救性手术的 14 例患者。我们回顾了综合手术结果,包括手术程序、术中发现和术后并发症。使用 Kaplan-Meier 估计计算总生存期(OS)。

结果

在接受药物治疗前的初始临床分期(c 期)为 8 例 III 期,5 例 IV 期,1 例为术后肺癌复发。手术的指征如下:10 例为局部控制复发或残留肿瘤,4 例为因治疗相关并发症而停止全身治疗。手术方式为肺段切除术(n=1)、肺叶切除术(n=4)、双肺叶切除术(n=3)、全肺切除术(n=6)和支气管成形术(n=7)。6 例患者出现 3 级或更高级别的术后并发症,仅 1 例发生 90 天死亡。

结论

我们的研究表明,在仔细选择手术程序和适应证的情况下,ICI 治疗后进行挽救性扩大手术的手术结果可能是积极的。

相似文献

1
Salvage extended surgery after immune-checkpoint inhibitor treatment for advanced non-small cell lung cancer.免疫检查点抑制剂治疗后挽救性扩大手术治疗晚期非小细胞肺癌。
Surg Today. 2024 Aug;54(8):917-926. doi: 10.1007/s00595-024-02812-2. Epub 2024 Mar 22.
2
Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?对于局部晚期非小细胞肺癌,在进行根治性放化疗后出现局部复发时,是否应考虑挽救性手术?
J Cardiothorac Surg. 2016 Jan 19;11:9. doi: 10.1186/s13019-016-0396-0.
3
Outcomes and pathologic response of primary lung cancer treated with tyrosine kinase inhibitor/immune checkpoint inhibitor before salvage surgery.酪氨酸激酶抑制剂/免疫检查点抑制剂治疗后挽救性手术治疗原发性肺癌的结果和病理反应。
Surg Today. 2024 Oct;54(10):1146-1153. doi: 10.1007/s00595-024-02811-3. Epub 2024 Mar 14.
4
Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer.根治性放化疗后非小细胞肺癌患者的挽救性手术。
Lung Cancer. 2019 Jul;133:117-122. doi: 10.1016/j.lungcan.2019.05.010. Epub 2019 May 13.
5
Salvage pulmonary resection in stages IIIb-IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review.免疫检查点抑制剂治疗后 IIIb-IV 期肺癌分阶段挽救性肺切除术:病例系列和文献复习。
J Surg Oncol. 2022 Feb;125(2):290-298. doi: 10.1002/jso.26691. Epub 2021 Sep 27.
6
Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective study.先前免疫治疗后晚期非小细胞肺癌的挽救性手术:一项回顾性研究。
J Cardiothorac Surg. 2023 Jul 20;18(1):235. doi: 10.1186/s13019-023-02310-5.
7
[Operability and Pathological Response of Non-Small Cell Lung Cancer (NSCLC) after Neoadjuvant Therapy with Immune Checkpoint Inhibition].免疫检查点抑制新辅助治疗后非小细胞肺癌(NSCLC)的可操作性及病理反应
Pneumologie. 2020 Nov;74(11):766-772. doi: 10.1055/a-1199-2029. Epub 2020 Aug 20.
8
Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.局部晚期非小细胞肺癌根治性放化疗后局部复发行挽救性手术后的长期生存情况
Thorac Cardiovasc Surg. 2018 Mar;66(2):135-141. doi: 10.1055/s-0037-1606597. Epub 2017 Oct 9.
9
Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.Ⅲ期非小细胞肺癌根治性放化疗后挽救性肺切除术的可行性和疗效
Interact Cardiovasc Thorac Surg. 2016 Dec;23(6):895-901. doi: 10.1093/icvts/ivw245. Epub 2016 Aug 19.
10
Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.非小细胞肺癌根治性放疗(>59 Gy)后挽救性肺切除术:手术及肿瘤学结局
Ann Thorac Surg. 2008 Nov;86(5):1632-8; discussion 1638-9. doi: 10.1016/j.athoracsur.2008.07.042.

引用本文的文献

1
Rescue Surgery for Advanced Stage Lung Cancer: A Systematic Review.晚期肺癌的挽救性手术:一项系统综述
Thorac Cancer. 2025 Aug;16(16):e70151. doi: 10.1111/1759-7714.70151.
2
Salvage Pulmonary Resection After Immune Checkpoint or Tyrosine Kinase Inhibitor Therapy for Initially Unresectable Non-Small-Cell Lung Cancer: A Systematic Review.免疫检查点或酪氨酸激酶抑制剂治疗后对初始不可切除的非小细胞肺癌进行挽救性肺切除术:一项系统评价
Biomedicines. 2025 Jun 24;13(7):1541. doi: 10.3390/biomedicines13071541.
3
Salvage Lung Resection of Aspergilloma Mimicking Tumor Regrowth after Immune Checkpoint Inhibitor Therapy for Stage IV Squamous Cell Lung Cancer: A Case Report.

本文引用的文献

1
Setting a quality indicator for actual surgery time relative to scheduled surgery time in the context of increasing robotic-assisted thoracic surgery cases.在机器人辅助胸腔手术病例不断增加的情况下,为实际手术时间相对于计划手术时间设定质量指标。
Gen Thorac Cardiovasc Surg. 2023 Jul;71(7):396-402. doi: 10.1007/s11748-022-01903-6. Epub 2022 Dec 30.
2
Salvage pulmonary resection in stages IIIb-IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review.免疫检查点抑制剂治疗后 IIIb-IV 期肺癌分阶段挽救性肺切除术:病例系列和文献复习。
J Surg Oncol. 2022 Feb;125(2):290-298. doi: 10.1002/jso.26691. Epub 2021 Sep 27.
3
免疫检查点抑制剂治疗IV期肺鳞状细胞癌后,挽救性肺切除治疗模仿肿瘤再生的曲霉菌球:一例报告
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.24-0096. Epub 2025 Mar 11.
Bronchoplastic Procedure Versus Pneumonectomy After High-dose Radiation for Non-small Cell Lung Cancer.
支气管成形术与全肺切除术治疗高剂量放疗后非小细胞肺癌的比较。
Ann Thorac Surg. 2021 Dec;112(6):1832-1840. doi: 10.1016/j.athoracsur.2020.12.016. Epub 2020 Dec 24.
4
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179.一项针对不可切除 III 期非小细胞肺癌患者在同期放化疗后行巩固性帕博利珠单抗治疗的 2 期临床试验:Hoosier Cancer Research Network LUN 14-179。
Cancer. 2020 Oct 1;126(19):4353-4361. doi: 10.1002/cncr.33083. Epub 2020 Jul 22.
5
Salvage Lung Resections After Definitive Chemoradiotherapy: A Safe and Effective Oncologic Option.根治性放化疗后挽救性肺切除术:一种安全有效的肿瘤治疗选择。
Ann Thorac Surg. 2020 Oct;110(4):1123-1130. doi: 10.1016/j.athoracsur.2020.04.035. Epub 2020 May 28.
6
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.阿替利珠单抗联合化疗一线治疗广泛期小细胞肺癌。
N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25.
7
Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors.免疫治疗后肺切除术治疗转移性或不可切除肿瘤的安全性和可行性。
Ann Thorac Surg. 2018 Jul;106(1):178-183. doi: 10.1016/j.athoracsur.2018.02.030. Epub 2018 Mar 14.
8
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.Durvalumab 用于 III 期非小细胞肺癌放化疗后的治疗。
N Engl J Med. 2017 Nov 16;377(20):1919-1929. doi: 10.1056/NEJMoa1709937. Epub 2017 Sep 8.
9
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.早期和局部晚期非小细胞肺癌(NSCLC):ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21. doi: 10.1093/annonc/mdx222.
10
Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer.食管癌与食管胃交界癌:第八版分期指南
J Thorac Oncol. 2017 Jan;12(1):36-42. doi: 10.1016/j.jtho.2016.10.016. Epub 2016 Oct 31.